ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Health-Related Quality of Life in R/R MM Treated With Teclistamab, a B-Cell Maturation Antigen x CD3-Bispecific Antibody: PROs in MajesTEC-1
By
ASCO 2022 Conference Coverage
FEATURING
Thomas Martin
By
ASCO 2022 Conference Coverage
FEATURING
Thomas Martin
Login to view comments.
Click here to Login
